专栏名称: 易凯资本
易凯资本新闻资讯发布官方平台
目录
相关文章推荐
牛村大牛  ·  陈小群:不想举牌,让利市场 ·  昨天  
牛村大牛  ·  陈小群:不想举牌,让利市场 ·  昨天  
51好读  ›  专栏  ›  易凯资本

《亚洲金融》专访王冉:19年易凯将积极而不激进

易凯资本  · 公众号  · 科技投资  · 2019-04-11 11:58

正文




近日,易凯资本创始人兼CEO王冉接受了FinanceAsia(《亚洲金融》)的采访,分享了他对资本市场未来趋势以及科创板前景的观点。本文英文版原文刊发于FinanceAsia官方网站。FinanceAsia对此次采访进行了编辑。【中文版附后】





FinanceAsia原文 英文版



After a tough 2018, there are some glimmers of optimism for Chinese investors this year.

The National People’s Congress had a number of positive messages for them and there is great enthusiasm for the Shanghai Stock Exchange's new technology innovation board. All good news.

Ran Wang, founding partner and chief executive of CEC Capital, shares his thoughts about the opportunities that lie ahead and his opinion of the latest technology innovation board.

Founded in 2000, investment bank CEC Capital focuses on healthcare, TMT and the consumer sector. It provides M&A, capital raising and asset management service for its clients in and outside China.

Wang sees huge opportunities for advanced manufacturing as the government pushes forward its round of industry upgrades.

Traditional manufacturing is expected to have the most opportunities as the production line becomes smarter. Investors usually chase investments in the latter stages of the manufacturing process. The front-end involves more investment in high-tech that is still not easily accepted by the market.

The technology innovation board is undoubtedly going to be the highlight of the year. Detailed listing regulations were released in March.

Wang cautions startups to be patient and not to IPO before their businesses are developed. Cautious investment will keep the new board on an even keel, something that will benefit the market as a whole.

The following is the conversation that Ran Wang had with FinanceAsia. This interview has been edited for brevity and clarity.



Q How would you characterise the Chinese private equity market in 2018?


A We saw a deficit for the first time. There was a slowdown in funds flowing into the private market, while outflows accelerated. If you view the market as a reservoir, the water level is declining. There will be a further impact in 2019 and 2020.

Secondly, there was a large adjustment near the end of last year and the effect has been passed on to the primary market. Some investors take a longer time to make decisions.

Previously there were projects at the venture capital stage that were asking for a price for the private equity stage. But investors are cautious about such transactions and are reluctant to do it.

The project cycle is lengthening, but the valuation system in the PE market has not changed. We expect the valuation correction to continue throughout the year, as the PE market adjustment has not yet completed.

Q Will the trend continue in 2019?

A It is quite possible that valuations will rationalise. In some sectors, which used to have a lot of valuation bubbles, the price will decline further.

The main problems lie in those companies with a high valuation, but which still need capital even though their business model is not yet profitable.

Such companies exist in different industries and sectors. Companies which depend on subsidies for income require continuous fundraising to survive.

Investors will have questions for these companies, and valuations will be a lot lower than before.

Q On which industries will CEC Capital focus in 2019?

A We will continue to focus on our strong points: healthcare, TMT [technology, media and telecoms and consumption]. We have an obvious advantage in healthcare, which has become a defensive investment sector in a volatile market. We will continue our investments here.

The second area is consumer goods where we see a lot of new opportunities. With the emergence of new consumer groups and goods, the replacement of new and old brands has brought many opportunities. Here we intend to strengthen our coverage capabilities further.

In the TMT sector, we will find new opportunities in the new generation of consumers, with new content, but overall, we see a greater focus on early-stage investment.

But there are also two relatively large adjustments, one is what is known as the industrial internet, which means opportunities for business clients. The market has heated up since last year.

Opportunities have emerged up and down the traditional production line as China wants to improve efficiency via industrial chain restructuring. This is in line with our existing projects and we have specifically restructured our company to focus more on industrial internet opportunities.

Another area is advanced manufacturing. This is a policy-driven industry and closely related to China's macroeconomy, using new technology to restructure the current manufacturing model.

Some investments may involve very high-tech research in fields such as new materials. But at the moment, most investments are in post-production manufacturing, more on applications.

For financial investors, high-tech materials are not yet commercialised and not ideal for investment.

Q How do you view the M&A market in China?

A It is still very much an underperforming and under-served market. A lot of capital was raised last year, but significant M&As are still relatively rare.

For M&A activities to grow, you will need a healthy secondary market, which is not readily available in China.

On top of this, so-called inverse valuations featuring trading multiples that are higher in private markets than in public ones have also made it hard for public buyers to swallow private market M&A targets.

That said, we do expect to see a lot more going forward. These buyout deals will most likely happen with companies that have a sound business model and healthy cash flows. Some of these targets will be old-school traditional players, but new economy buyout targets will also emerge.

Q What is the outlook for the technology innovation board in Shanghai?

A The new technology innovation board is significant in many ways. First and foremost, the registration-based (disclosure-based) system and the new listing criteria is a big leap forward of fundamental importance. We hope it will lead to overarching reforms across the entire A-share market.

Second, the pricing mechanism, which is putting more in the hands of supply and demand and other market dynamics, is also a significant improvement vis-à-vis the old 23 times PE ratio guidelines.

In the short term, though, we anticipate that the first crop of companies listed on the new board will see their prices shoot through the roof, which may not necessarily be a good thing for the long haul. If too much money chases too little supply, that could spell trouble.

While it is clear that the government wants the new board to attract and support certain industries and verticals of strategic importance to China’s future development into a global superpower, we strongly believe that making the technology innovation board inclusive and not overly emphasising sectoral characteristics would benefit China more in the long run.

Q What do startups think of the new board?

A Many of them are taking a wait-and-see attitude. If they are onshore entities readying for a domestic IPO, then, of course, having the technology innovation board as an additional option would be a huge plus, provided that they can qualify under the current requirements.

But if they have already been structured into offshore entities with a VIE [variable interest entity] structure, then they would probably want to stay put and see if they could get listed on the new tech board with a VIE structure.

The general rule of the thumb for our clients is that when market environments are stable with a lot of certainties, you can contemplate onshore/offshore restructuring to achieve a particular purpose.

When the market is tumultuous and visibility is low, however, it’s probably better to focus on building a stronger business first and worry about capital market options later.

Q Are you worried about price inflation for the new board?

A We do have concerns. If the price is higher than the true value of the company, the subsequent stock price plunge will definitely have a negative effect on the technology innovation board. The best way is to let prices fluctuate within a reasonable range.

Q What trends are you seeing in Chinese fundraising at the moment?

A First, allocation of capital is becoming more concentrated in the hands of a smaller number of market-leading general partners (GPs) and top players in large vertical markets. The supply of capital for mediocre GPs and average entrepreneurs is definitely shrinking.

Second, there is a lot of reflection on the overall valuation approach. It used to be the case that people would look at comparable transactions completed by what they considered as top-tier investors and take them as the default benchmarks.

Today more and more people are beginning to question the validity of those valuations in the first place - are they really supported by robust methodologies or just the results of some random happenings?

Third, we are seeing an influx of late-stage VCs and private equity players moving into earlier stages to lower their average prices down the road.

In other words, they are going into earlier rounds not because they want to become angel investors or venture capitalists, but because they want to find a company in which they can pour in millions, even billions, of dollars down the road at an earlier stage: and yes, at a much cheaper price.

Q Will the technology innovation board in 2019 activate the RMB capital pool?

A The launch of the new technology innovation board will certainly draw some fresh RMB capital into the market. But for most truly innovative Chinese startups, it is still the deep-pocketed US dollar investors that are doing most of the heavy lifting.

Q Will capital raising in 2019 be dominated by USD or RMB?

A We have been seeing a steady decline in the number of active RMB investors since 2018.

In general, US dollar investment tends to be a much more stable source of capital given the nature of US dollar limited partners (LPs).

For 2019, we believe US dollar investment in China’s primary market will remain relatively stable, with some new faces such as certain hedge funds, sovereign wealth funds and family offices unfamiliar to the Chinese market popping up here and there.

In terms of RMB supply, although there is still a lot of money in the market, it is primarily flowing into the hands of a small number of state-owned asset management platforms.

Given that much of the capital inflow is coming from various levels of government and state-owned enterprises, it is only natural that a lot of the investment activities in the RMB space will be policy driven.

Being politically correct will be essential to secure large RMB investments from state-owned investment platforms and financial institutions.

Q Are US dollar investors still looking at China despite the economic slowdown?

A While the economic growth in China is more sluggish, of all the major economies that exceed $1 trillion (along with India) it still offers the highest economic growth. At the end of the day, the combination of its massive scale and a growth rate of around 6% still makes it very attractive to a lot of outside capital.

Second, in anticipation of an economic slowdown in China and the worsening of other structural issues, some global funds have pulled back on their China allocation over the past couple of years. With the US stock markets continuing experiencing downward adjustment pressure, some are quitting slowly from China for a re-adjusted portfolio balance.

Finally, as China's stock markets open up and some Chinese companies are included in global indices, those like MSCI are drawing traditional global asset managers and hedge funds into the game.

In order to cover the market well, they would have to hire their China analysts and investment professionals. As they build out their China presence, they are beginning to ask themselves the question: “why not going in a little bit earlier to capture more upside?”

Q What's your view on overseas investment by Chinese companies?

A The wave of Chinese companies aggressively snatching up assets overseas has subsided a bit due to both Chinese domestic policies as well as concerns from the Committee on Foreign Investment in the US.

There are still sporadic asset purchases, but it is becoming more challenging in terms of securing government approvals - often from both sides, foreign direct investment permission on foreign exchanges, and deal financing in general.

In the meantime, we are seeing more and more Chinese companies beginning to do business in other parts of the world. India, Southeast Asia, and even the Middle East are all emerging as the new playground for Chinese entrepreneurs. An increasing number of them have chosen to fight the battle overseas as opposed to facing extremely fierce competition at home.

Q What about CEC Capital's capital allocation overseas?

A Even with the headwinds in Sino-US relations, we are continuously beefing up our presence in the US. We already have a team of about 20 professionals in two locations, Los Angeles and San Francisco.

While truly cross border deals only account for a relatively small portion of our deal pipeline, many of our large capital deals will require joint efforts on both sides.

Our US team will not only provide strategic value in deal execution but will also serve as a strong extension of our ECM capabilities in the overseas market.

Unlike some of our competitors, who put greater emphasis on IPOs and secondary market investors, we want to focus on building the most elaborate and extensive global investor networks for the private market.

On the direct investment side, we are also looking at what many call “global startups” - startup companies that have duel teams and duel home markets in China and the US.

Q What will CEC’s overall strategy be in 2019?

A Stay alive and healthy, groom a new generation of leaders and oil the wheels on both investment banking and asset management.

We want to make sure that we continue to lead the pack in healthcare, build market leadership and expertise around the new consumer revolution, and not miss the boat on the next big wave in TMT.

In addition to our investment banking activities, we plan to raise our second US dollar fund. This will focus on the consumer market which will encompass healthcare and entertainment sectors and will leverage the resources of our overall platform as we have done in the past with our first US dollar fund and RMB fund.

Given the overall economic environment, it’s probably not the best year to be super aggressive in all different directions, but we will be highly proactive on the things we really care about.




中文版



在经历了艰难的2018年后,今年,中国投资者看到了一些乐观的迹象。全国人民代表大会向投资者们传递了许多积极的信息,并对上海证券交易所的新科创板充满了热情。


易凯资本创始合伙人兼首席执行官王冉分享了他对未来机遇的看法以及对科创板的最新观点。


易凯资本成立于2000年,专注于医疗、TMT和消费领域。为国内外客户提供并购、融资和资产管理服务。


王冉认为,随着政府推动这一轮产业升级,先进制造业将拥有巨大的机遇。随着生产线更加智能化,传统制造业有望获得最多的机会。虽然想投高科技项目的玩家日益增长,但是这样的项目只能吸收一定的资金量。


另外,科创板无疑将成为今年的亮点。科创版上市细则已于3月发布。王冉提醒初创企业要有耐心,不要在业务发展成熟之前进行IPO。谨慎的投资将使科创板保持平稳,这将有利于整个市场。


以下是王冉与Finance Asia(亚洲金融)的对话。为了简洁明了,本次采访已做适当编辑。



Q: 您如何看待2018年一级市场的总体情况?


A: 2018年,我们第一次看到一级市场的资金流逆差。资金流入一级市场的速度有所放缓,而流出资金(投入项目上的资金)还在加速。如果把市场看作一个蓄水池,那么这个蓄水池的存量正在下降。2019年和2020年将显现出进一步的影响。


其次,二级市场在去年年末的时候出现了较大的调整,其影响已经传导到了一级市场。投资人做决策的周期拉长。


以前,在风险投资阶段会有一些项目要求以私募股权阶段的价格进行交易。但目前,投资者对此类交易持谨慎态度,不愿这样做。


项目周期正在延长,但一级市场的估值体系仍需调整。由于价格传导并不十分充分,所以我们预期,一级市场估值的调整还将在全年持续。



Q 2019年这一趋势会持续下去吗?


A :2019年估值很可能会有合理化趋势。在一些泡沫较多、非理性成分能较大的阶段,估值会理性化下跌。


最主要的是那些本身没有被验证商业模式,在现金流上还需要持续补血,并且估值在前几轮融资中被炒得较高的公司。这些公司存在于不同的行业和领域,需要靠后续持续筹资才能生存下去。投资者对这些公司会有所质疑,所以它们的估值会有较大的调整。



Q 2019年,易凯资本将重点关注哪个行业?


A :我们仍然会关注过去一直聚焦的三个领域:医疗、TMT(科技、媒体和通讯)以及消费。我们在医疗方面有明显的优势,在动荡的市场中,医疗已经成为一项防御性的投资。2019年,我们还会持续不断地投入。


其次是消费领域,我们从中看到了许多新机会。新消费群体和消费品类的出现,以及新老品牌之间的更替,带来了大量机会。在这一领域,我们也计划进一步加强覆盖能力。


而在TMT方面,我们将在新一代消费者身上看到更多机会,针对年轻一代会出现许多新的产品内容。总体而言,会向早期做偏移。


同时,还有两个比较大的调整。一个是产业互联网方面,也就是 to B 的机会。从去年开始,这类市场就不断升温。因为中国每一个产业链都有重组的机会,不断重塑产业链来提升效率。这一趋势与我们现有的项目一致,并且,我们对公司进行了专门的内部调整,以此更多地关注这类机会,在产业互联网方面有一个更好的布局。


另外一个重要的调整出现在先进制造领域。这是一个政策驱动的产业,并且和中国的宏观经济有着紧密的关系,它通过使用新技术来重塑当前的制造业模式。一些资本会涉及科技前沿领域,比如新材料。但目前,大多数产业资本涉及到的是产业后端的,更多的是应用领域,而不是在最科技前沿的材料上投资。因为对于金融投资者来说,高科技产品还没有商业化,不是一个适合投资的阶段。



Q 您如何看待中国的并购市场?


A :我们觉得这是一个未被开发的市场。去年所有新经济投行在投融资领域的份额很高,但重大并购加在一起仍然占比较低。从某种角度讲,并购交易稳定发展的前提是二级市场要兴旺,而现在的中国还不具备。除此之外,所谓的反向估值(以私募市场的交易倍数高于公募市场的交易倍数为特征)也使得公共市场买家难以接受私人市场并购目标。


我们的确希望将来能看到更多并购交易,而这种交易最有可能发生在具有良好的商业模式和健康现金流的公司中。收购目标将是老派的传统玩家,但新的收购目标也将出现。



Q 科创板的前景如何?


A :从许多方面讲,科创板建立的意义都是重大的,最大的意义在于制度创新。首先是基于注册(披露)制和新的上市标准是一个重大飞跃。我们希望这将带来整个A股市场的全面改革。







请到「今天看啥」查看全文